Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina

Circulation

Volumn 93, Issue 4, 1996, Pages 691-696

  Parker, John D ^b   Parker, Andrea B ^c   Farrell, Bernice ^a   Parker, John O ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c SOCAR RESEARCH SA   (Switzerland)

Author keywords

angina; diuretics; nitroglycerin

Indexed keywords

AMILORIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE;

ADULT; ANGINA PECTORIS; ANTIDIURESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; EXERCISE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030053949     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.4.691     Document Type: Article

References (36)

1. Dalal JJ, Yao L, Parker JO. Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J Am Coll Cardiol. 1983;2:115-120.
2. Thadani U, Fung H-L, Darke AC, Parker JO. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose response relation during acute and sustained therapy. Am J Cardiol. 1982;49:411-419.
3. Reichek N, Priest C, Zimrin D, St John Sutton M. Antianginal effects of nitroglycerin patches. Am J Cardiol. 1984;54:1-7.
4. Parker JO, Fung H-L, Ruggirello D, Stone JA. Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation. 1983;68:1074-1080.
5. Parker JO. Nitrate therapy in stable angina pectoris. N Engl J Med. 1987;316:1635-1642.
6. Packer M. Clinical significance of nitrate tolerance in patients with chronic heart failure. Eur Heart J. 1989;10(suppl A):20-25.
7. Abrams J. Clinical aspects of nitrate tolerance. Eur Heart J. 1991; 12(suppl E):42-52.
8. Packer M. What causes tolerance to nitroglycerine? The 100 year old mystery continues. J Am Coll Cardiol. 1990;16:932-935.
9. Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counterregulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation. 1991;84:2336-2345.
10. Parker JD, Parker JO. Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin. J Am Coll Cardiol. 1993;21:1445-1453.
11. Lis Y, Bennett D, Lambert G, Robson D. A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Med. 1984;10:179-184.
12. Dupuis J, Lalonde G, Lemieux R, Rouleau JL. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol. 1990; 16:923-931.
13. Parker JD, Farrell B, Fenton T, Parker JO. Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin. J Am Coll Cardiol. 1992;20:616-622.
14. Sussex BA, Campbell NRC, Raju MK, McKay DW. The anti-anginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment. Clin Pharmacol Ther. 1994;56:229-234.
15. Parker JO, Case RB, Khaja F, Ledwich JR, Armstrong PW. The influence of changes in blood volume on angina pectoris: a study of the effect of phlebotomy. Circulation. 1970;41:593-604.
16. Nechwatal W, Konig E, Isbary J, Greding H, Stauch M. Haemodynamic and electrocardiographic effects of frusemide during supine exercise in patients with angina pectoris. Br Heart J. 1980;44: 67-74.
17. Floyd CB, Domenet JG. Chlorthalidone in the treatment of angina pectoris. Practitioner. 1973;210:559-565.
18. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Pharmacol. 1979;8:7-20.
19. Abdollah A, Moffat JA, Armstrong PW. N-Acetylcysteine does not modify nitroglycerin-induced tolerance in canine vascular rings. J Cardiovasc Pharmacol. 1987;9:445-450.
20. Imhof P, Renwald D, Muller P, Howald H, Burkart F. Circulatory counter-regulations induced by continuous administration of nitroglycerin. J Pharmacol Exp Ther. 1989;11:409-414.
21. Muiesan ML, Agabiti-Rosei E, Romanelli M, Beschi M, Castellano M, Cefis M, Cerri B, Pollavini G, Muiesan B. Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris is related to sympathetic and renin-angiotensin-aldosterone activity. Eur Heart J. 1992;13:15-21.
22. Feldman RL, Conti CR. Relief of myocardial ischemia with nitroglycerin: what is the mechanism? Circulation. 1981;64:1098-1100.
23. Alderman EL, Davies RO, Crowley JJ, Lopes MG, Brooker JC, Friedman JP, Graham AF, Matlof HJ, Harrison DC. Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation. 1975;51:964-972.
24. Wagniart P, Ferguson RJ, Chaitman BR, Achard F, Benacerraf A, Delanguenhagen B, Morin B, Pasternac A, Bourassa MG. Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris. Circulation. 1982;66:22-28.
25. Parker JO, Farrell B, Lahey KA, Moe G. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med. 1987;316:1440-1444.
26. Conway J, Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation. 1960;21:21-27.
27. Hansen J. Hydrochlorothiazide in the treatment of hypertension: the effects on blood volume, exchangeable sodium and blood pressure. Acta Med Scand. 1968;183:317-321.
28. Tarazi RC, Dustan HP, Fröhlich ED. Long-term thiazide therapy in essential hypertension: evidence for persistent alteration in plasma volume and renin activity. Circulation. 1970;41:709-717.
29. Leth A. Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide. Circulation. 1970;42:479-485.
30. Shah S, Khatri I, Freis E. Mechanism of antihypertensive effect of thiazide diuretics. Am Heart J. 1978;95:611-618.
31. Fam WM, McGregor M. Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res. 1968;22:649-659.
32. + exchange inhibitors against cardiac injury produced by ischemia/ reperfusion, hypoxia/reoxygenation, and the calcium paradox. J Cardiovasc Pharmacol. 1993;21:172-178.
33. + exchange. Am J Physiol. 1988; 255:608-615.
34. Pierce GN, Cole WC, Liu K, Massaeli H, Maddaford TG, Chen YJ, McPherson CD, Jain S, Sontag D. Modulation of cardiac performance by amiloride and selected derivatives of amiloride. J Pharmacol Exp Ther. 1993;265:1280-1291.
35. Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G. Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study. JAMA. 1988;259:1976-1982.
36. Packer M. Drug therapy: combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med. 1989;320:709-718.